SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-024933
Filing Date
2016-02-08
Accepted
2016-02-08 16:57:36
Documents
40
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bota20151231_10q.htm 10-Q 775060
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 18600
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 18555
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 12809
  Complete submission text file 0001437749-16-024933.txt   2811134

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS bota-20151231.xml EX-101.INS 520204
6 EXHIBIT 101.SCH bota-20151231.xsd EX-101.SCH 25551
7 EXHIBIT 101.CAL bota-20151231_cal.xml EX-101.CAL 30003
8 EXHIBIT 101.DEF bota-20151231_def.xml EX-101.DEF 157603
9 EXHIBIT 101.LAB bota-20151231_lab.xml EX-101.LAB 141097
10 EXHIBIT 101.PRE bota-20151231_pre.xml EX-101.PRE 171931
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 161396235
SIC: 2836 Biological Products, (No Diagnostic Substances)